Bvf Inc Cidara Therapeutics, Inc. Transaction History

Bvf Inc

$3.34 Billion
Q1 2024

A detailed history of Bvf Inc transactions in Cidara Therapeutics, Inc. stock. As of the latest transaction made, Bvf Inc holds 6,861,127 shares of CDTX stock, worth $76.9 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

6,861,127

Previous 6,861,127 -0.0%

Holding current value

$76.9 Million

Previous $5.42 Million 16.46%

% of portfolio

0.19%

Previous 0.14%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$1.18 - $2.18 $2.46 Million - $4.54 Million	2,084,223 Added 43.63%	6,861,127 $8.71 Million
Q3 2021 Nov 15, 2021	BUY	$1.48 - $2.35 $636,400 - $1.01 Million	430,000 Added 9.89%	4,776,904 $10.7 Million
Q2 2021 Aug 16, 2021	BUY	$1.87 - $2.7 $1.14 Million - $1.64 Million	607,200 Added 16.24%	4,346,904 $8.78 Million
Q4 2020 Feb 12, 2021	SELL	$1.99 - $3.25 $53,730 - $87,750	-27,000 Reduced 0.72%	3,739,704 $7.48 Million
Q3 2020 Nov 13, 2020	BUY	$2.85 - $4.1 $220,877 - $317,754	77,501 Added 2.1%	3,766,704 $10.7 Million

Q2 2020 Aug 14, 2020	SELL	$2.39 - $4.0 $325,307 - $544,448	-136,112 Reduced 3.56%	3,689,203 $13.6 Million
Q1 2020 May 15, 2020	BUY	$1.74 - $4.26 $1.98 Million - $4.85 Million	1,137,577 Added 42.32%	3,825,315 $9.49 Million
Q3 2019 Nov 14, 2019	BUY	$1.25 - $2.35 $43,553 - $81,881	34,843 Added 1.31%	2,687,738 $5.36 Million
Q2 2019 Aug 14, 2019	BUY	$1.49 - $2.94 $1.4 Million - $2.77 Million	942,211 Added 55.08%	2,652,895 $4.46 Million
Q1 2019 May 15, 2019	SELL	$2.35 - $3.27 $2.81 Million - $3.9 Million	-1,194,000 Reduced 41.11%	1,710,684 $4.53 Million
Q4 2018 Feb 14, 2019	BUY	$2.1 - $4.5 $2.05 Million - $4.38 Million	974,014 Added 50.45%	2,904,684 $6.83 Million
Q2 2018 Aug 14, 2018	BUY	$3.75 - $6.05 $7.24 Million - $11.7 Million	1,930,670 New	1,930,670 $10 Million

Others Institutions Holding CDTX

# of Institutions

Shares Held

22.2M

Call Options Held

2.7K

Put Options Held

100

View Full List

About Cidara Therapeutics, Inc.

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $786M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

More about CDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Account